È pronto lo strumento che calcola in base a posti letto e tipologia di pazienti il il personale necessario a ogni ospedale. L’obiettivo è sostituire l’attuale vincolo sulle assunzioni
Risultati per: Algoritmo sulla Deprescrizione degli Inibitori della Pompa Protonica (PPI)
Questo è quello che abbiamo trovato per te
Un algoritmo potrebbe migliorare diagnosi nei tumori del sangue
Studio tra Trieste e Londra pubblicato su Nature Communications
Un algoritmo potrebbe migliorare diagnosi nei tumori del sangue
Studio tra Trieste e Londra pubblicato su Nature Communications
Abstract 13912: Insights From a Multi-Center Consortium for HCV-Viremic Donor Heart Transplant: Outcomes Are Excellent Across Regimens Often Without Major Changes to Statin or PPI
Circulation, Volume 148, Issue Suppl_1, Page A13912-A13912, November 6, 2023. Introduction:With the availability of pangenotypic direct-acting antivirals (DAA) for facile, curative treatment of hepatitis C virus (HCV) infections, HCV-viremic donors are utilized regularly to partially address the shortage of suitable organs for heart transplant (HT). This multi-center, retrospective registry characterized HT outcomes from HCV-positive donors.Methods:Of 138 isolated HT recipients from 8 sites across the US, the most common DAAs were the pangenotypic antiviral combinations sofosbuvir-velpatasvir (SOF/VEL, n=39) and glecaprevir-pibrentasvir (GLE/PIB, n=76); these 115 cases were analyzed in terms of primary graft dysfunction (PGD), episodes of rejection ≥ pAMR1 and/or Grade 2R, post-transplant infection, sustained virologic response at 12 weeks post-treatment (SVR12), and survival up to 1 year.Results:Comparing these two most common pangenotypic regimens, HT recipients differed in their listing status (p
Cure e intelligenza artificiale: la privacy e il rischio dell’algoritmo che discrimina
Tra le richieste del garante c’è la trasparenza, la supervisione dell’uomo sulle decisioni e la necessità di evitare discriminazioni sulle cure a causa degli algoritmi.
Terapia protonica contro il cancro disponibile a Singapore
Può ridurre gli effetti collaterali rispetto alla radioterapia
Malattie renali genetiche,algoritmo aiuta individuarle prima
Studio coordinato dall’ospedale Meyer e Università di Firenze
Algoritmo di deprescrizione degli Inibitori di Pompa Protonica (IPP, PPI)
Salute: Riccardi, riapertura Ppi Gemona è lavoro di tutti
Quanti e quali sono i pazienti con scompenso cardiaco eleggibili agli inibitori SGLT2? Risposte dalla combinazione di database di assistenza sanitaria amministrativa e di assistenza primaria.
Impact of patient and public (PPI) involvement in the Life After Prostate Cancer Diagnosis (LAPCD) study: a mixed-methods study
Objectives
Standardised reporting of patient and public involvement (PPI) in research studies is needed to facilitate learning about how to achieve effective PPI. The aim of this evaluation was to explore the impact of PPI in a large UK study, the Life After Prostate Cancer Diagnosis (LAPCD) study, and to explore the facilitators and challenges experienced.
Design
Mixed-methods study using an online survey and semistructured interviews. Survey and topic guide were informed by systematic review evidence of the impact of PPI and by realist evaluation. Descriptive analysis of survey data and thematic analysis of interview data were conducted. Results are reported using the GRIPP2 (Guidance for Reporting Involvement of Patients and the Public, Version 2) reporting guidelines.
Setting
LAPCD study, a UK-wide patient-reported outcome study.
Participants
User Advisory Group (UAG) members (n=9) and researchers (n=29) from the LAPCD study.
Results
Impact was greatest on improving survey design and topic guides for interviews, enhancing clarity of patient-facing materials, informing best practices around data collection and ensuring steering group meetings were grounded in what is important to the patient. Further impacts included ensuring patient-focused dissemination of study findings at conference presentations and in lay summaries.
Facilitating context factors included clear aims, time to contribute, confidence to contribute, and feeling valued and supported by researchers and other UAG members. Facilitating mechanisms included embedding the UAG within the study as a separate workstream, allocating time and resources to the UAG reflecting the value of input, and putting in place clear communication channels. Hindering factors included time commitment, geographical distance, and lack of standardised feedback mechanisms.
Conclusion
Including PPI as an integral component of the LAPCD study and providing the right context and mechanisms for involving the UAG helped maximise the programme’s effectiveness and impact.
In adults using oral anticoagulants, PPI use may be associated with lower risk for upper GI bleeding
Annals of Internal Medicine, Ahead of Print.
Use of a positive psychology intervention (PPI) to promote the psychological well-being of children living in poverty: study protocol for a feasibility randomised controlled trial
Introduction
Poverty has a detrimental influence on psychological well-being of children. Existing evidence shows that positive psychology interventions are possible to mitigate such impact. Despite criticisms that positive psychology resembles a scientific Pollyannaism that promotes overly positivity, positive psychology is not the scientific Pollyannaism that denies the difficulties and emotions that people may experience. Whereas, positive psychology acknowledges the difficulties and emotions, alongside with building up human resilience, strength and growth to face adversity. This study examined the feasibility of implementing a positive psychology intervention among Hong Kong Chinese children living in poverty.
Methods
A feasibility randomised controlled trial will be conducted. A convenience sample of 120 children aged 13–17 years will be recruited from a community centre in Kwai Tsing district. Participants who are randomised into the experimental group will join a 1.5-hour workshop covering four positive psychology techniques: (1) gratitude visits/letters, (2) three good things, (3) you at your best and (4) using signature strengths. A booster intervention will be provided at 1 week. Control group participants will not receive any intervention. Assessments will be conducted at baseline and at 1-week, 1-month, 3-month and 6-month follow-ups.
Analysis
Descriptive statistics will be used to calculate the feasibility measures. Effect sizes on psychological outcomes (ie, self-esteem, depressive symptoms and quality of life) will be estimated by mixed between-within subjects analysis of variance using partial eta squared with poverty (yes, no) entering into the model as a factor.
Ethics and dissemination
Ethical approval has been obtained from the Hong Kong Polytechnic University Institutional Review Broad. We will obtain parental consent as our subjects are below 18 years old. Findings from this study will be disseminated via international publications and conferences.
Trial registration number
NCT04875507.